CLINICAL_TRIALS
trial_result
· 2014-07-02
Clinical Trial Update: PROTECT Continued Access Post Marketing Surveillance Trial [Phase 4]
Summary
The PROTECT continued access post-marketing surveillance Phase 4 trial sponsored by Medtronic Vascular has completed, with results posted in July 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Medtronic Vascular | Conditions: Coronary Artery Disease, Autosomal Dominant, 1 | Phase 4 | Status: COMPLETED | Results posted: 2014-07-02